Website review ketabon.health
Ketabon
Generated on January 17 2026 17:54 PM
Old data? UPDATE !
The score is 63/100
SEO Content
Title
Ketabon
Length : 7
Ideally, your title should contain between 10 and 70 characters (spaces included). Use this free tool to calculate text length.
Description
Ketabon develops an oral prolonged-release formulation of ketamine (KET01) for Treatment-Resistant Depression with minimal dissociative side effects, helping 94 million patients globally.
Length : 187
Ideally, your meta description should contain between 70 and 160 characters (spaces included). Use this free tool to calculate text length.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| title | Treating Treatment Resistant Depression |
| description | Ketabon develops an oral prolonged-release formulation of ketamine (KET01) for Treatment-Resistant Depression with minimal dissociative side effects, helping 94 million patients globally. |
| url | https://www.ketabon.health |
| image | https://www.ketabon.health/img/og_ketabon.jpg |
| type | website |
| locale | en_US |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 14 | 14 | 0 | 0 | 0 |
- [H1] T r e a t i n g Depression
- [H2] Ketabon – accessing ketamine’santidepressant potential
- [H2] A growing burdenon patients and society
- [H2] TreatingDepression
- [H2] Arguably the greatest breakthroughin the field of depression in over 60 years
- [H2] Change the future ofDepression Treatment with us
- [H2] AboutKetabon
- [H2] Potential rapid-actingtreatment option
- [H2] Phase 2 trial
- [H2] Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation,KET01, and Intranasal SPRAVATO®
- [H2] Strong Potential in the Early Treatment of MDD,Addressing a Serious Unmet Medical Need
- [H2] Entering Pivotal Phase 3 Clinical Trialsand targeting market entry by 2028
- [H2] Ketabon program
- [H2] News
- [H2] Events
- [H3] Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024
- [H3] Ketabon To Present Advancements In At-Home Ketamine Therapy ...
- [H3] Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO® ...
- [H3] Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression ...
- [H3] Ray of HopeA New, Take-At-Home Ketamine Pill is a Gamechanger for Treatment-Resistant Depression ...
- [H3] HMNC BRAIN HEALTH AND DEVELCO PHARMAANNOUNCE LAST PATIENT BEING RANDOMIZED IN ORAL PROLONGED-RELEASE KETAMINE (KET01) TRIAL ...
- [H3] FIRST PATIENT DOSED IN SECOND PHASE 2 ADD-ONKETAMINE TRIAL IN TREATMENT-RESISTANT DEPRESSION (TRD)
- [H3] PROMISING PRELIMINARY RESULS IN TRD,SUGGESTING ANTIDEPRESSANT EFFICACY AND PLACEBO-LEVEL DISSOCIATIVE SIDE EFFECTS
- [H3] PHASE II PROOF-OF-CONCEPTTO STUDY TRD PATIENTS RESISTANT TO STANDARD ANTIDEPRESSANTS
- [H3] CNS Summit 2023 Poster #3
- [H3] CNS Summit 2023 Poster #18
- [H3] Dr. Markus Zimmer, Co-CEO
- [H3] Dr. Maximilian Döbler, Co-CEO
- [H3] Dr. Hans Eriksson, CMO
Images
We found 19 images on this web page.
Good, most or all of your images have alt attributes.
Text/HTML Ratio
Ratio : 58%
Ideal! This page's ratio of text to HTML code is between 25 and 70 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Great, there are no Iframes detected on this page.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.
In-page links
We found a total of 11 links including 1 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| About us | Internal | Passing Juice |
| Medical Need | Internal | Passing Juice |
| Our Aim | Internal | Passing Juice |
| News | Internal | Passing Juice |
| Events | Internal | Passing Juice |
| Investors | Internal | Passing Juice |
| Contact | Internal | Passing Juice |
| Disclaimer | Internal | Passing Juice |
| Download | Internal | Passing Juice |
| Legal notice | Internal | Passing Juice |
| Privacy Policy | Internal | Passing Juice |
SEO Keywords
Keywords Cloud
treatment ket01 depression ketabon close potential more patients read ketamine
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| treatment | 26 |  |
|
 |
|
| depression | 25 | |
|
|
|
| more | 24 | |
|
|
|
| ket01 | 23 | |
|
|
|
| ketamine | 23 | |
|
|
|
Usability
Url
Domain : ketabon.health
Length : 14
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Perfect, your website has few JavaScript files. |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| /sitemap.xml |
Robots.txt
https://ketabon.health/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Free SEO Testing Tool
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.